Amino Acid Sequence
Z-Leu-Leu-Leu-al
General description
Potent, reversible, and cell-permeable proteasome inhibitor (Ki = 4 nM). Reduces the degradation of ubiquitin-conjugated proteins in mammalian cells and permeable stains of yeast by the 26S complex without affecting its ATPase or isopeptidase activities. Activates c-Jun N-terminal kinase (JNK1) which initiates apoptosis. Inhibits NF-κB activation (IC50 = 3 µM). This material is ≥95% pure by HPLC. A material with ≥98% purity by HPLC (Cat. No. 474790) is also available. Also available as a 20 mM solution in DMSO (Cat. No. 474788).
Potent, reversible, and cell-permeable proteasome inhibitor (Ki = 4 nM). Reduces the degradation of ubiquitin-conjugated proteins in mammalian cells and permeable stains of yeast by the 26S complex without affecting its ATPase or isopeptidase activities. Activates c-Jun N-terminal kinase (JNK1) which initiates apoptosis. Inhibits NF-κB activation (IC50 = 3 µM). This material is ≥95% pure by HPLC. A material with ≥98% purity by HPLC (Cat. No. 474790) is also available.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Steinhilb, M.L., et al. 2001. J. Biol. Chem.276, 4476.Meriin, A.B., et al. 1998. J. Biol. Chem. 273, 6373.Adams, J., and Stein, R. 1996. Ann. Rep. Med. Chem.31, 279.Klafki, H.W., et al. 1996. J. Biol. Chem.271, 2865.Lee, D.H., and Goldberg, A.L., 1996. J. Biol. Chem.271, 27280.Wiertz, E.J., et al. 1996. Cell84, 769.Jensen, T.J., et al. 1995. Cell 83, 129.Read, M.A., et al. 1995. Immunity2, 493.Rock, K.L., et al. 1994. Cell 78, 761.
Packaging
Packaged under inert gas
10 mg in Glass bottle
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: